Intratumor heterogeneity is an important mediator of poor outcomes in many cancers, including breast cancer. Genetic subclones frequently contribute to this heterogeneity; however, their growth dynamics and interactions remain poorly understood. TED-347 PIK3CA and HER2 alterations are known to coexist in breast and other cancers. Herein, we…[Read more]